* Integra Lifesciences Holdings Corp IART.OQ reported
quarterly
adjusted earnings of 63 cents per share for the quarter ended
in June, lower than the same quarter last year, when the company
reported EPS of 71 cents. The mean expectation of
thirteen analysts for the quarter was for earnings of 62 cents
per share. Wall Street expected results to range from 60 cents
to 64 cents per share.
* Revenue rose 9.7% to $418.18 million from a year ago;
analysts
expected $413.15 million.
* Integra Lifesciences Holdings Corp's reported EPS for the
quarter was a loss of 16 cents.
* The company reported a quarterly loss of $12.4 million.
* Integra Lifesciences Holdings Corp shares had risen
by 7.9% this
quarter and lost 27.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 17%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 8
"hold" and 3 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Integra
Lifesciences Holdings Corp is $31.00
This summary was machine generated from LSEG data July 29 at
04:27 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.62 0.63 Beat
Mar. 31 2024 0.55 0.55 Met
Dec. 31 2023 0.90 0.89 Missed
Sep. 30 2023 0.78 0.76 Missed